Delivery Order SPE2DE24D0021-SPE2D625F3U9V
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order contract on July 14, 2025, valued at $2,934.90 for the supply of National Flu/Respiratory Syncytial Virus/COVID-19 positive controls in 6x 0.5 milliliter research use only (RUO) format. The contract is fixed-price with economic price adjustment provisions and will be fulfilled at the vendor's Pittsburgh, Pennsylvania location, with an ultimate completion date of July 21, 2025. This delivery order represents a child contract with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,137.88 on September 10, 2025, by the Medical Supply Chain division of the Department of Defense to supply National Flu/RSV/COVID positive controls in 6x0.5ml format for research use only (RUO). This is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of September 17, 2025. The contract will be performed in Pittsburgh, Pennsylvania. This award represents a child contract...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,061.60 on September 5, 2025, for the supply of National Flu/RSV/COVID Positive controls in 6x0.5mL format for research use only (RUO). This fixed-price contract with economic price adjustment will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 12, 2025. The award was made without a set-aside designation through open competition by the Medical Supply Chain, a defense-focused federal...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,509.10 on August 12, 2025, for the supply of National Flu/Respiratory Syncytial Virus/COVID-19 positive control materials in 6x0.5 milliliter format designated for research use only (RUO). This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 19, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded without a set-aside designation,...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract valued at $2,934.90 on September 3, 2025, by the Defense Department's Medical Supply Chain division for the procurement of National Flu/RSV/COVID positive test kits in 6x 0.5mL Reagent Use Only (RUO) format. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and has an ultimate completion date of September 10, 2025. Performance will take place in Pittsburgh, Pennsylvania. This...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,196.00 by the Medical Supply Chain division of the Department of Defense on July 23, 2025. The contract, which operates under a fixed-price structure with economic price adjustment provisions, covers the supply of National Flu/RSV/COVID positive test kits in 6x0.5mL formats for research use only (RUO). This is a child contract with an ultimate completion date of July 30, 2025, and performance will be executed in...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,327.00 by the Defense Medical Supply Chain on September 19, 2025, for the provision of National Flu/RSV/COVID Positive 6x 0.5ML RUO (Research Use Only) testing supplies. The contract, which represents a child award under a larger vehicle, is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,445.75 on August 21, 2025, by the Medical Supply Chain, a defense-oriented federal agency. The contract, which uses fixed price with economic price adjustment pricing, covers the supply of National Influenza/Respiratory Syncytial Virus/COVID-19 positive control materials in 6x0.5mL format for research use only (RUO). This is a child contract with no set-aside designation, indicating open competition procurement....
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $1,477.33 from the Defense Medical Supply Chain for National Influenza/Respiratory Syncytial Virus/COVID-19 positive control specimens in 6x 0.5 milliliter format for research use only. Awarded on June 5, 2025, with an ultimate completion date of June 12, 2025, this contract carries no set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurements. The order will be fulfilled...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $1,467.45 from the Medical Supply Chain, a defense-oriented federal agency, for the procurement of National Flu/RSV/COVID positive test kits (6x0.5mL, research use only). The contract, awarded on July 28, 2025, with an ultimate completion date of August 4, 2025, represents a child contract under a larger vehicle and will be performed in Pittsburgh, PA. This award reflects Fisher Scientific's established role as a...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3U9VDelivery Order
Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,270.00 for the supply of National Flu/RSV/COVID Positive control materials in 6x0.5mL quantities designated for Research Use Only (RUO). The award, issued on April 21, 2025, with an ultimate completion date of April 23, 2025, represents a child contract under a larger vehicle and was funded by the Department of Defense's Medical Supply Chain division. The contract was awarded without a set-aside designation through open competition, reflecting Fisher Scientific's established capability to compete for federal scientific supply contracts. Performance will be fulfilled from the company's Pittsburgh, Pennsylvania location. This delivery order supports diagnostic and research testing capabilities within the Defense Department's medical supply chain operations. Fisher Scientific, a major federal supplier of laboratory and medical equipment since its registration with SAM.gov in 2001, regularly provides specialized testing solutions and reagents to defense and civilian agencies. The fixed-price contract with economic price adjustment pricing structure reflects the standardized nature of these control materials, which are essential components for validating laboratory assays related to influenza, respiratory syncytial virus, and coronavirus detection procedures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/21/25 |